These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 21911015)

  • 1. A poly(ethylene glycol)-based surfactant for formulation of drug-loaded mucus penetrating particles.
    Mert O; Lai SK; Ensign L; Yang M; Wang YY; Wood J; Hanes J
    J Control Release; 2012 Feb; 157(3):455-60. PubMed ID: 21911015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticle penetration of human cervicovaginal mucus: the effect of polyvinyl alcohol.
    Yang M; Lai SK; Yu T; Wang YY; Happe C; Zhong W; Zhang M; Anonuevo A; Fridley C; Hung A; Fu J; Hanes J
    J Control Release; 2014 Oct; 192():202-8. PubMed ID: 25090196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Surface Polyethylene Glycol (PEG) Density on Biodegradable Nanoparticle Transport in Mucus ex Vivo and Distribution in Vivo.
    Xu Q; Ensign LM; Boylan NJ; Schön A; Gong X; Yang JC; Lamb NW; Cai S; Yu T; Freire E; Hanes J
    ACS Nano; 2015 Sep; 9(9):9217-27. PubMed ID: 26301576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and optimization of nonionic surfactants emulsified nimesulide-loaded PLGA-based nanoparticles by design of experiments.
    Turk CT; Oz UC; Serim TM; Hascicek C
    AAPS PharmSciTech; 2014 Feb; 15(1):161-76. PubMed ID: 24222270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin E-Oligo(methyl diglycol l-glutamate) as a Biocompatible and Functional Surfactant for Facile Preparation of Active Tumor-Targeting PLGA Nanoparticles.
    Wu J; Zhang J; Deng C; Meng F; Zhong Z
    Biomacromolecules; 2016 Jul; 17(7):2367-74. PubMed ID: 27305935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier.
    Tang BC; Dawson M; Lai SK; Wang YY; Suk JS; Yang M; Zeitlin P; Boyle MP; Fu J; Hanes J
    Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19268-73. PubMed ID: 19901335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS.
    Mu L; Feng SS
    J Control Release; 2003 Jan; 86(1):33-48. PubMed ID: 12490371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y; Pan J; Feng SS
    Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus.
    Cu Y; Saltzman WM
    Mol Pharm; 2009; 6(1):173-81. PubMed ID: 19053536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
    Rafiei P; Haddadi A
    Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scalable method to produce biodegradable nanoparticles that rapidly penetrate human mucus.
    Xu Q; Boylan NJ; Cai S; Miao B; Patel H; Hanes J
    J Control Release; 2013 Sep; 170(2):279-86. PubMed ID: 23751567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodegradable mucus-penetrating nanoparticles composed of diblock copolymers of polyethylene glycol and poly(lactic-
    Yu T; Wang YY; Yang M; Schneider C; Zhong W; Pulicare S; Choi WJ; Mert O; Fu J; Lai SK; Hanes J
    Drug Deliv Transl Res; 2012 Apr; 2(2):. PubMed ID: 24205449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood-brain barrier.
    Chen YC; Hsieh WY; Lee WF; Zeng DT
    J Biomater Appl; 2013 Mar; 27(7):909-22. PubMed ID: 22207601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo studies on vitamin E TPGS-emulsified poly(D,L-lactic-co-glycolic acid) nanoparticles for paclitaxel formulation.
    Win KY; Feng SS
    Biomaterials; 2006 Apr; 27(10):2285-91. PubMed ID: 16313953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release.
    Zhang Z; Feng SS
    Biomaterials; 2006 Jan; 27(2):262-70. PubMed ID: 16024075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies.
    Ocal H; Arica-Yegin B; Vural I; Goracinova K; Caliş S
    Drug Dev Ind Pharm; 2014 Apr; 40(4):560-7. PubMed ID: 23596973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid.
    Keum CG; Noh YW; Baek JS; Lim JH; Hwang CJ; Na YG; Shin SC; Cho CW
    Int J Nanomedicine; 2011; 6():2225-34. PubMed ID: 22114486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PLGA/TPGS nanoparticles for controlled release of paclitaxel: effects of the emulsifier and drug loading ratio.
    Mu L; Feng SS
    Pharm Res; 2003 Nov; 20(11):1864-72. PubMed ID: 14661934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodegradable polymeric nanospheres formed by temperature-induced phase transition in a mixture of poly(lactide-co-glycolide) and poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) triblock copolymer.
    Lee KE; Kim BK; Yuk SH
    Biomacromolecules; 2002; 3(5):1115-9. PubMed ID: 12217061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled preparation and antitumor efficacy of vitamin E TPGS-functionalized PLGA nanoparticles for delivery of paclitaxel.
    Wang G; Yu B; Wu Y; Huang B; Yuan Y; Liu CS
    Int J Pharm; 2013 Mar; 446(1-2):24-33. PubMed ID: 23402977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.